C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation

Andrologia

Volumn 40, Issue 6, 2008, Pages 398-400

  Giltay, E J ^a   Haider, A ^b   Saad, F ^c,d   Gooren, L J ^e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Private Urology Praxis   (Germany)

^c BAYER PHARMA AG   (Germany)

^d GULF MEDICAL UNIVERSITY   (United Arab Emirates)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ageing male symptoms; C reactive protein level; Low grade inflammation; Quality of life; Testosterone administration

Indexed keywords

C REACTIVE PROTEIN; TESTOSTERONE;

AGING; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SMOKING;

ADULT; AGED; AGING; ANDROGENS; C-REACTIVE PROTEIN; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 57249092757     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2008.00873.x     Document Type: Article

References (12)

1. Daig I, Heinemann LA, Kim S, Leungwattanakij S, Badia X, Myon E, Moore C, Saad F, Potthoff P, Thai DM (2003) The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes 1 : 77 88.
2. Danner M, Kasl SV, Abramson JL, Vaccarino V (2003) Association between depression and elevated C-reactive protein. Psychosom Med 65 : 347 356.
3. Guler N, Batyraliev T, Dulger H, Ozkara C, Tuncer M, Aslan S, Okut H, Agirbasli M (2006) The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting. Int J Cardiol 109 : 339 343.
4. Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39 : 687 699.
5. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M (2006) The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 60 : 825 830.
6. Liukkonen T, Rasanen P, Ruokonen A, Laitinen J, Jokelainen J, Leinonen M, Meyer-Rochow VB, Timonen M (2007) C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom Med 69 : 756 761.
7. Moore C, Huebler D, Zimmermann T, Heinemann LA, Saad F, Thai DM (2004) The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 46 : 80 87.
8. Nakhai-Pour HR, Grobbee DE, Emmelot-Vonk MH, Bots ML, Verhaar HJ, van der Schouw YT (2007) Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial. Am Heart J 154 : 1228.
9. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M (2003) Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54 : 566 572.
10. Pope HG, Jr., Cohane GH, Kanayama G, Siegel AJ, Hudson JI (2003) Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 160 : 105 111.
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 : 973 979.
12. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS (2006) Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med 166 : 465 471.